Wednesday, April 29, 2020

Lancet study: No statistically significant clinical benefits of remdesivir in COVID patients



from India | The Indian Express https://ift.tt/2VPsTDq
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)